2015 annual financial data
Corcept Therapeutics 2015 Net income growth
Direct answer
Net income growth was 79.58%.
Operating income was -3,443,000 USD and net income was -6,408,000 USD.
Operating cash flow was 3,130,000 USD.
Get free Corcept Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 50,286,000 USD
- Operating income
- -3,443,000 USD
- Net income
- -6,408,000 USD
- Operating cash flow
- 3,130,000 USD